Search company, investor...

Next Breath

nextbreath.net

Stage

Incubator/Accelerator | Alive

About Next Breath

Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.

Headquarters Location

1450 South Rolling Road

Baltimore, Maryland, 21227,

United States

410-455-5904

Missing: Next Breath's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Next Breath's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Next Breath Patents

Next Breath has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/25/2012

11/26/2013

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Medical treatments

Grant

Application Date

6/25/2012

Grant Date

11/26/2013

Title

Related Topics

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Medical treatments

Status

Grant

Latest Next Breath News

Your next breath (Guest Column)

Sep 20, 2013

Your next breath Contributed -Sep 20, 2013 / 5:00 am | Story:98820 Do you or someone you know snore? Are you restless in your sleep? Do you wake up feeling not quite refreshed and ready to face your day with the energy you’d like to have? Do you wake up frequently in the night? Are you tired or exhausted during your day? If you answered yes to any of those questions, you may be suffering from a sleep breathing disorder (SBD). Photo: Thinkstock.com It is estimated by the World Health Organization (WHO) that as many as 100,000,000 suffer from sleep apnea worldwide. Obstructive sleep apnea (OSA) is the sleep breathing disorder with the most awareness, and is condition whereby a person stops breathing for a period of time because their airway is literally obstructed. However, it is not the only SBD. The numbers of people suffering goes up when you include the people that partially stop breathing, those that just require a lot more effort to breathe at night, those that don’t receive a signal from their brains to breathe, and those that develop reduced blood oxygen levels at night. All of these SBDs have a dramatic impact on a person’s body and physiology. These include lack of oxygen for the brain, fragmented sleep resulting in insufficient deep or reparative sleep, and chronic stress on one’s nervous system. The result is decreased immune function, increased sense of pain, lack of cognition/memory, and metabolic disorders such as high blood pressure, obesity and type II diabetes. Science is very clear about the significance or SBDs and OSA when we look at the stats and the studies. Untreated OSA can put a person 23 times more at risk for having a heart attack. Studies have demonstrated that 65 – 85% of stroke victims had OSA. Further, untreated OSA can shorten a person’s life by up to 20% depending on severity. These are to highlight but a few of the serious issues associated with SBD’s. You might be wondering why a dentist is writing on this topic. The answer is simple. A person often sees their dentist more than any other health care practitioner, and a dentist with training can recognize the risk factors and bring the topic to a patient’s attention. Such a dentist could also be able to easily and painlessly test a person’s quality of sleep with the use of portable monitoring equipment. Then to take it a step further, many of the SBDs are treatable with the use of a custom fit appliance known as a mandibular advancement device (MAD). This is a serious health risk with large ramifications in terms of a person’s quality of life as well as length of life. To really appreciate that simply think about this statement, the most important thing to any living being is their next breath. Photo: Contributed   Dr. Mark Provencher is a general dentist having graduated with distinction from the University of Alberta in 1997. He is active in numerous professional organizations and is a perpetual student that prefers a proactive, holistic, why based approach to care. He has hundreds of hours of extra training in the areas of neuromuscular dentistry, sleep dentistry, cosmetic and complex restorative dentistry. He lives in Kelowna with his beautiful wife and two young children.

Next Breath Frequently Asked Questions (FAQ)

  • Where is Next Breath's headquarters?

    Next Breath's headquarters is located at 1450 South Rolling Road, Baltimore.

  • What is Next Breath's latest funding round?

    Next Breath's latest funding round is Incubator/Accelerator.

  • Who are the investors of Next Breath?

    Investors of Next Breath include bwtech@UMBC Incubator & Accelerator.

  • Who are Next Breath's competitors?

    Competitors of Next Breath include Mirus Bio, PolyPid, OptiNose, EZRA Innovations, Quinnova Pharmaceuticals, Iontera, OctoPlus, Transpharma, Oriel Therapeutics, Talima Therapeutics and 16 more.

Compare Next Breath to Competitors

C
Core Tech Solutions

Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.

M
MedManage Systems

MedManage Systems, Inc. aims to provide drug sampling solutions. The company's OmniSampleSM Solution aims to allow pharmaceutical companies to intensify physician use of trial medications, thereby increasing product revenues.

E
Erydel

EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.

M
Medi-Stream

Medi-Stream Pty Limited designs, develops and commercializes drug delivery technologies and devices focused on "˜Air Stream Medication'. The first commercial product released to the market is an Asthma medication delivery device, which has been soft launched to pharmacies under the trade name of Sportshaler. Innovation Capital committed to a $2.5m investment in April 2008.

G
Glide Pharma

Glide Pharma, formerly Caretek Medical, is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of pharmaceuticals and vaccines using its Glide SDI - the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments.

G
Gel Med Sciences

GelMed Sciences, Inc. is commercializing three new agriculture product inventions initially developed by the Penn State University Research Foundation (PSRF). The company's offerings include a Poultry Feed Withdrawal Supplement (PFWS), a Livestock Genetic Marker, and a Gel Drug Delivery Systems which all aim to improve quality and/or output of agricultural products.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.